HEALTHCARE REALTY REPORTS THIRD QUARTER 2026 RESULTS AND FURTHER INCREASES FULL
HEALTHCARE REALTY REPORTS THIRD QUARTER 2026 RESULTS AND FURTHER INCREASES FULL YEAR 2026 GUIDANCE
NASHVILLE, Tennessee, October 29, 2026. Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the third quarter ended September 30, 2026. I n addition, the Company announced an increased 2026 Normalized FFO guidance range of $1.65 to $1.67 per share (diluted), a $0.02 increase at the midpoint from July guidance, and an increased Same Store Cash NOI growth guidance range of 5.00% to 5.25% (+75bps increase at the low end and +25bps at the high end from July guidance).
• GAAP Net loss of $(0.05) per share, NAREIT FFO of $0.38 per share, Normalized FFO of $0.42 per share, and FAD of $110 million (payout ratio of 76%)
• Same store cash NOI growth of 5.1%, tenant retention of 88.0% and cash leasing spreads averaging 8.6%
• Third quarter lease executions totaled 1.5 million square feet, including 430,000 square feet of new lease executions
• Since last quarter, the Company acquired $211 million of assets (approximately $42 million at share) in its strategic joint venture with KKR
• Since last quarter, the Company sold $68 million of assets, bringing year-to- date disposition activity to $136 million ($187 million including loan receivable repayments)
• Repurchased 4.2 million shares of common stock through early October at an average share price of $17.74
During the third quarter, the Company executed 329 new and renewal leases for 1.5 million square feet with a weighted average lease term of 5.9 years and average annual escalators of 3.1%. Key highlights include:
• Ascension Health. 203,000 square feet of new and renewal leases in Nashville across five on campus properties
• Cedars Sinai Medical Center. 59,000 square feet of renewal leases in Los Angeles at a 95% occupied building
• Mount Carmel Health System. 59,000 square feet of renewal leases across four properties in Columbus, OH
• Indiana University Health. 38,000 square feet of renewal leases in Indianapolis, maintaining occupancy of more than 97% across two properties
Since last quarter, the Company acqu ired $211 million of assets (approximately $42 m illion at share) in its strategic joint venture with KKR. Selected transactions include:
• Charleston, SC. Acquired two health system anchored, Class A MOBs for $56 million ($11 million investment at share). The Company now owns 10 properties totaling 436,000 square feet in the market
• Seattle, WA. Acquired a 33,000 square foot health system anchored MOB for $17 million ($3 million investment at share), further strengthening the Company's footprint in the Seattle market
Since last quarter, the Company has disposed of $68 million of assets, bringing year-to-date disposition activity to $136 million. Selected transactions include:
• Atlanta, GA. The Company completed a previously announced $36 million direct sale of a 59,000 square foot MOB to the affiliated hospital
• Chicago, IL. During the quarter, the Company sold two properties for aggregate proceeds of $23 million and entered into a contract to sell the remaining property in the Chicago MSA. Upon completion of the sale, the Company will have fully exited the Chicago market
During the third quarter, the Company leased approximately 112,000 square feet and invested approximately $25 million across its redevelopment portfolio. Also during the quarter, the Company completed the redevelopment of a 40,400 square foot MOB in Raleigh, NC and commenced the redevelopment of a 60,500 square foot MOB in Austin, TX.
As of September 30, 2026, the Company had a pproximately $1.6 billion of liquidity across the revolving facility (net of commercial paper issuance), delayed draw term loan, and cash on hand.
In the third quarter and early October, the Company repurchased 4.2 million shares of common stock at an average price of $17.74 per share for a total of $75 million.
On October 26, 2026, the Company renewed its share repurchase program for the next 12 months with total authorization up to $500 million, replacing the expiring authorization from October 2025.
The Board unanimously approved a common stock dividend in the amount of $0.24 per share to be pa id on November 20, 2026, to Class A common stockholders of record on November 10, 2026 . Additionally, the eligible holders of operating partnership units will receive a distribution of $0.24 per unit, equivalent to the Company's Class A common stock dividend.
The 2026 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any. The Company's guidance also does not include any future acquisitions, developments or share issuances or repurchases, other than as discussed in the detailed guidance assumptions on Page 10 of the Q3 2026 Supplemental. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results or timing vary from these assumptions, the Company's expectations may change. See Page 10 of the Q3 2026 Supplemental for additional details and assumptions.
On Friday, October 30, 2026, at 9:00 a.m. Eastern Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.
Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address.
Healthcare Realty Trust Incorporated (NYSE: HR) is the largest public, pure-play owner, operator and developer of medical outpatient buildings in the United States.
For additional information contact [email protected]. Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “target,” “intend,” “plan,” “estimate,” “project,” “continue,” “should,” “could," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: the Company’s expected results may not be achieved; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; pandemics or other health crises; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption “Risk Factors” and elsewhere in the Company’s filings and reports with the SEC, including the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company’s filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing. For a detailed discussion of the Company’s risk factors, please refer to the Company's filings with the SEC, including this report and the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
ASSETS Q3 2026 Q4 2025 Real estate properties Land $1,040,660 $1,060,254 Buildings and improvements 8,673,665 8,514,165 Lease intangibles 378,664 455,254 Personal property 7,624 7,056 Investment in financing 6,017 123,249 receivables, net Financing lease right-of-use 73,894 75,083 assets Land held for development 35,564 57,535 Total real estate investments 10,216,088 10,292,596 Less accumulated depreciation and -2,602,921 -2,397,795 amortization Total real estate investments, 7,613,167 7,894,801 net Cash and cash equivalents 17,499 26,172 Assets held for sale, net 150,085 143,580 Operating lease right-of-use 202,383 204,906 assets Investments in unconsolidated joint 481,521 453,607 ventures Other assets, net 495,108 487,795 Total assets $8,959,763 $9,210,861 LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, AND STOCKHOLDERS' EQUITY Liabilities Notes and bonds payable $4,249,159 $3,911,423 Accounts payable and accrued 176,630 211,071 liabilities Liabilities of properties held 13,510 15,160 for sale Operating lease liabilities 163,793 162,922 Financing lease liabilities 74,475 73,130 Other liabilities 147,567 160,530 Total liabilities 4,825,134 4,534,236 Redeemable non-controlling 3,748 3,252 interests Stockholders' equity Preferred stock, $0.01 par value; — — 200,000 shares authorized Common stock, $0.01 par value; 1,000,000 3,400 3,516 shares authorized Additional paid-in capital 8,895,212 9,137,257 Accumulated other comprehensive income 8,316 -5,174 (loss) Cumulative net income attributable to 68,913 128,238 common stockholders Cumulative dividends -4,895,426 -4,646,944 Total stockholders' equity 4,080,415 4,616,893 Non-controlling interest 50,466 56,480 Total equity 4,130,881 4,673,373 Total liabilities, redeemable non-controlling interests, and $8,959,763 $9,210,861 stockholders' equity
1 Normalizing items primarily include restructuring, severance-related costs and other.
2 Potential common shares are not included in the computation of diluted earnings per share when a loss exists (or when dividends paid are greater than income), as the effect would be an antidilutive per share amount. As a result, the outstanding limited partnership units in the Company's operating partnership ("OP"), totaling 4,229,701 units were not included.
1 The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding o f 722,102 for th e three months ended September 30, 2026. Also includes the diluted impa ct of 4,229,701 OP units outstanding.
Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, and funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non- GAAP financial measures management considers relevant to the Company's business and useful to investors.
The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.
FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, and share-based compensation expense; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.
Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.
Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income plus interest from financing receivables less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, financing receivable amortization, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.
Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.
The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction through the application of additional resources, including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.
Any recently acquired property will be included in the same store pool once the Company has owned the property for five full quarters. Newly developed or redeveloped properties will be included in the same store pool five full quarters after substantial completion.
Full text with the tables
News Release
HEALTHCARE REALTY REPORTS THIRD QUARTER 2026 RESULTS AND FURTHER INCREASES FULL
YEAR 2026 GUIDANCE
NASHVILLE, Tennessee, October 29, 2026. Healthcare Realty Trust Incorporated
(NYSE:HR) today announced results for the third quarter ended September 30,
2026. I n addition, the Company announced an increased 2026 Normalized FFO
guidance range of $1.65 to $1.67 per share (diluted), a $0.02 increase at the
midpoint from July guidance, and an increased Same Store Cash NOI growth
guidance range of 5.00% to 5.25% (+75bps increase at the low end and +25bps at
the high end from July guidance).
THIRD QUARTER 2026 HIGHLIGHTS
• GAAP Net loss of $(0.05) per share, NAREIT FFO of $0.38 per share, Normalized
FFO of $0.42 per share, and FAD of $110 million (payout ratio of 76%)
• Same store cash NOI growth of 5.1%, tenant retention of 88.0% and cash leasing
spreads averaging 8.6%
• Third quarter lease executions totaled 1.5 million square feet, including
430,000 square feet of new lease executions
• Since last quarter, the Company acquired $211 million of assets (approximately
$42 million at share) in its strategic joint venture with KKR
• Since last quarter, the Company sold $68 million of assets, bringing year-to-
date disposition activity to $136 million ($187 million including loan
receivable repayments)
• Net Debt to Adjusted EBITDA of 5.5x
• Repurchased 4.2 million shares of common stock through early October at an
average share price of $17.74
THIRD QUARTER 2026 RESULTS
THIRD
QUART…
ENDED
2026 2025
──────────────────────────────────────────────────────────────────────────────
(in
thou…
exce… AMOUNT PER AMOUNT PER
per SHARE SHARE
share
amou…
GAAP
Net $(15,… $(0.… $(57… $(0.…
loss
NARE…
FFO, $131,… $0.38 $118… $0.34
dilu…
Norm…
FFO, $145,… $0.42 $145… $0.41
dilu…
LEASING ACTIVITY
During the third quarter, the Company executed 329 new and renewal leases for
1.5 million square feet with a weighted average lease term of 5.9 years and
average annual escalators of 3.1%. Key highlights include:
• Ascension Health. 203,000 square feet of new and renewal leases in Nashville
across five on campus properties
• Cedars Sinai Medical Center. 59,000 square feet of renewal leases in Los
Angeles at a 95% occupied building
• Mount Carmel Health System. 59,000 square feet of renewal leases across four
properties in Columbus, OH
• Indiana University Health. 38,000 square feet of renewal leases in
Indianapolis, maintaining occupancy of more than 97% across two properties
CAPITAL ALLOCATION
Acquisition Activity
Since last quarter, the Company acqu ired $211 million of assets (approximately
$42 m illion at share) in its strategic joint venture with KKR. Selected
transactions include:
• Charleston, SC. Acquired two health system anchored, Class A MOBs for $56
million ($11 million investment at share). The Company now owns 10 properties
totaling 436,000 square feet in the market
• Seattle, WA. Acquired a 33,000 square foot health system anchored MOB for $17
million ($3 million investment at share), further strengthening the Company's
footprint in the Seattle market
HEALTHCARE REALTY TRUST INCORPORATED HEALTHCAREREALTY.COM | PAGE 1 OF 7
Disposition Activity
Since last quarter, the Company has disposed of $68 million of assets, bringing
year-to-date disposition activity to $136 million. Selected transactions
include:
• Atlanta, GA. The Company completed a previously announced $36 million direct
sale of a 59,000 square foot MOB to the affiliated hospital
• Chicago, IL. During the quarter, the Company sold two properties for aggregate
proceeds of $23 million and entered into a contract to sell the remaining
property in the Chicago MSA. Upon completion of the sale, the Company will have
fully exited the Chicago market
Development and Redevelopment
During the third quarter, the Company leased approximately 112,000 square feet
and invested approximately $25 million across its redevelopment portfolio. Also
during the quarter, the Company completed the redevelopment of a 40,400 square
foot MOB in Raleigh, NC and commenced the redevelopment of a 60,500 square foot
MOB in Austin, TX.
Balance Sheet
As of September 30, 2026, the Company had a pproximately $1.6 billion of
liquidity across the revolving facility (net of commercial paper issuance),
delayed draw term loan, and cash on hand.
In the third quarter and early October, the Company repurchased 4.2 million
shares of common stock at an average price of $17.74 per share for a total of
$75 million.
On October 26, 2026, the Company renewed its share repurchase program for the
next 12 months with total authorization up to $500 million, replacing the
expiring authorization from October 2025.
DIVIDEND
The Board unanimously approved a common stock dividend in the amount of $0.24
per share to be pa id on November 20, 2026, to Class A common stockholders of
record on November 10, 2026 . Additionally, the eligible holders of operating
partnership units will receive a distribution of $0.24 per unit, equivalent to
the Company's Class A common stock dividend.
GUIDANCE
The Company further increased full year 2026 guidance ranges as follows:
20…
GU…
AC… PR… CU…
(J…
Q3 LOW HIGH LOW HI…
20…
E…
p… $(… $(… $(0… $(… $(…
s…
N…
F… $0… $1… $1.… $1… $1…
p…
s…
N…
F… $0… $1… $1.… $1… $1…
p…
s…
S…
S…
C… 5.1 % 4.… % 5.… % 5.00 % 5.25 %
N…
g…
The 2026 annual guidance range reflects the Company's view of current and future
market conditions, including assumptions with respect to rental rates, occupancy
levels, interest rates, and operating and general and administrative expenses.
The Company's guidance does not contemplate impacts from gains or losses from
dispositions, potential impairments, or debt extinguishment costs, if any. The
Company's guidance also does not include any future acquisitions, developments
or share issuances or repurchases, other than as discussed in the detailed
guidance assumptions on Page 10 of the Q3 2026 Supplemental. There can be no
assurance that the Company's actual results will not be materially higher or
lower than these expectations. If actual results or timing vary from these
assumptions, the Company's expectations may change. See Page 10 of the Q3 2026
Supplemental for additional details and assumptions.
EARNINGS CALL
On Friday, October 30, 2026, at 9:00 a.m. Eastern Time, Healthcare Realty Trust
has scheduled a conference call to discuss earnings results, quarterly
activities, general operations of the Company and industry trends.
Simultaneously, a webcast of the conference call will be available to interested
parties at https://investors.healthcarerealty.com/corporate-profile/webcasts
under the Investor Relations section. A webcast replay will be available
following the call at the same address.
Live Conference Call Access Details:
• Domestic Dial-In Number: +1 833-461-5787
HEALTHCARE REALTY TRUST INCORPORATED HEALTHCAREREALTY.COM | PAGE 2 OF 7
• All Other Locations: +1 585-542-9983
• Conference ID Number: 162 480 934
ABOUT HEALTHCARE REALTY
Healthcare Realty Trust Incorporated (NYSE: HR) is the largest public, pure-play
owner, operator and developer of medical outpatient buildings in the United
States.
For additional information contact [email protected].
Additional information regarding the Company, including this quarter's
operations, can be found at www.healthcarerealty.com. In addition to the
historical information contained within, this press release contains certain
forward-looking statements with respect to the Company. Forward-looking
statements include all statements that do not relate solely to historical or
current facts and can be identified by the use of words such as “may,” “will,”
“expect,” “believe,” “anticipate,” “target,” “intend,” “plan,” “estimate,”
“project,” “continue,” “should,” “could," "budget" and other comparable terms.
These forward-looking statements are based on the Company's current plans,
objectives, estimates, expectations and intentions and inherently involve
significant risks and uncertainties. Such risks and uncertainties include, among
other things, the following: the Company’s expected results may not be achieved;
risks related to future opportunities and plans for the Company, including the
uncertainty of expected future financial performance and results of the Company;
pandemics or other health crises; increases in interest rates; the availability
and cost of capital at expected rates; competition for quality assets; negative
developments in the operating results or financial condition of the Company's
tenants, including, but not limited to, their ability to pay rent; the Company's
ability to reposition or sell facilities with profitable results; the Company's
ability to release space at similar rates as vacancies occur; the Company's
ability to renew expiring leases; government regulations affecting tenants'
Medicare and Medicaid reimbursement rates and operational requirements;
unanticipated difficulties and/or expenditures relating to future acquisitions
and developments; changes in rules or practices governing the Company's
financial reporting; the Company may be required under purchase options to sell
properties and may not be able to reinvest the proceeds from such sales at rates
of return equal to the return received on the properties sold; uninsured or
underinsured losses related to casualty or liability; the incurrence of
impairment charges on its real estate properties or other assets; other legal
and operational matters; and other risks and uncertainties affecting the
Company, including those described from time to time under the caption “Risk
Factors” and elsewhere in the Company’s filings and reports with the SEC,
including the Company's Annual Report on Form 10-K for the year ended December
31, 2025. Moreover, other risks and uncertainties of which the Company is not
currently aware may also affect the Company's forward-looking statements and may
cause actual results and the timing of events to differ materially from those
anticipated. The forward-looking statements made in this communication are made
only as of the date hereof or as of the dates indicated in the forward-looking
statements, even if they are subsequently made available by the Company on its
website or otherwise. The Company undertakes no obligation to update or
supplement any forward-looking statements to reflect actual results, new
information, future events, changes in its expectations or other circumstances
that exist after the date as of which the forward-looking statements were made,
except as required by law. Stockholders and investors are cautioned not to
unduly rely on such forward-looking statements when evaluating the information
presented in the Company’s filings and reports, including, without limitation,
estimates and projections regarding the performance of development projects the
Company is pursuing. For a detailed discussion of the Company’s risk factors,
please refer to the Company's filings with the SEC, including this report and
the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
HEALTHCARE REALTY TRUST INCORPORATED HEALTHCAREREALTY.COM | PAGE 3 OF 7
Balance Sheet
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
ASSETS
Q3 2026 Q4 2025
Real estate properties
Land $1,040,660 $1,060,254
Buildings and improvements 8,673,665 8,514,165
Lease intangibles 378,664 455,254
Personal property 7,624 7,056
Investment in financing 6,017 123,249
receivables, net
Financing lease right-of-use 73,894 75,083
assets
Land held for development 35,564 57,535
Total real estate investments 10,216,088 10,292,596
Less accumulated depreciation
and -2,602,921 -2,397,795
amortization
Total real estate investments, 7,613,167 7,894,801
net
Cash and cash equivalents 17,499 26,172
Assets held for sale, net 150,085 143,580
Operating lease right-of-use 202,383 204,906
assets
Investments in unconsolidated
joint 481,521 453,607
ventures
Other assets, net 495,108 487,795
Total assets $8,959,763 $9,210,861
LIABILITIES, REDEEMABLE
NON-CONTROLLING
INTERESTS, AND STOCKHOLDERS'
EQUITY
Liabilities
Notes and bonds payable $4,249,159 $3,911,423
Accounts payable and accrued 176,630 211,071
liabilities
Liabilities of properties held 13,510 15,160
for sale
Operating lease liabilities 163,793 162,922
Financing lease liabilities 74,475 73,130
Other liabilities 147,567 160,530
Total liabilities 4,825,134 4,534,236
Redeemable non-controlling 3,748 3,252
interests
Stockholders' equity
Preferred stock, $0.01 par
value; — —
200,000 shares authorized
Common stock, $0.01 par value;
1,000,000 3,400 3,516
shares authorized
Additional paid-in capital 8,895,212 9,137,257
Accumulated other
comprehensive income 8,316 -5,174
(loss)
Cumulative net income
attributable to 68,913 128,238
common stockholders
Cumulative dividends -4,895,426 -4,646,944
Total stockholders' equity 4,080,415 4,616,893
Non-controlling interest 50,466 56,480
Total equity 4,130,881 4,673,373
Total liabilities, redeemable
non-controlling interests, and $8,959,763 $9,210,861
stockholders' equity
HEALTHCARE REALTY TRUST INCORPORATED HEALTHCAREREALTY.COM | PAGE 4 OF 7
Income Statements
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
THIRD YEAR
QUAR… TO FULL
ENDED 2026 2025 DATE 2026 2025 YEAR 2025
──────────────────────────────────────────────────────────────────────────────
Rev…
Ren… $277… $287… $815… $863… $1,1…
inc…
Int… 1,125 3,480 8,103 10,6… 14,2…
inc…
Oth… 7,915 6,886 23,6… 20,2… 28,2…
ope…
Tot… 286,… 297,… 847,… 894,… 1,18…
rev…
Exp…
Pro… 102,… 107,… 301,… 321,… 424,…
ope…
Gen…
and 12,4… 21,7… 44,1… 58,7… 72,5…
adm…
Nor… -991 -12,… -10,… -22,… -26,…
ite…
Nor…
gen… 11,4… 9,725 33,6… 35,9… 46,2…
and
adm…
Tra… 1,693 125 4,102 1,729 2,029
cos…
Dep…
and 128,… 143,… 385,… 453,… 588,…
amo…
Tot… 244,… 273,… 734,… 835,… 1,08…
exp…
Oth…
inc…
(ex…
Int…
exp…
bef… -35,… -41,… -103… -129… -166…
mer…
fair
val…
Mer…
fair -9,1… -10,… -30,… -31,… -42,…
val…
adj…
Int… -44,… -52,… -133… -160… -208…
exp…
Gain
on
sal…
of
real 2,476 76,7… 16,9… 99,6… 235,…
est…
pro…
and
oth…
ass…
Loss
on
ext… — -286 -1,7… -286 -451
of
debt
Imp…
of
real
est…
ass… -16,… -104… -57,… -258… -364…
and
cre…
loss
rec…
(re…
Equ…
inc…
(lo…
from 816 287 4,241 446 -188
unc…
joi…
ven…
Int…
and
oth… -108 -2,8… -82 -3,1… -3,5…
inc…
(ex…
net
Tot…
oth… -57,… -83,… -172… -322… -342…
inc…
(ex…
Net $(15… $(58… $(59… $(26… $(24…
loss
Net
loss
att… 96 806 461 3,614 3,414
to
non…
int…
Net
loss
att… $(15… $(57… $(59… $(26… $(24…
to
com…
sto…
Bas…
ear…
per $(0.… $(0.… $(0.… $(0.… $(0.…
com…
sha…
Dil…
ear…
per $(0.… $(0.… $(0.… $(0.… $(0.…
com…
sha…
Wei…
ave…
com…
sha… 340,… 349,… 343,… 349,… 349,…
out…
-
bas…
Wei…
ave…
com…
sha… 340,… 349,… 343,… 349,… 349,…
out…
-
dil…
1 Normalizing items primarily include restructuring, severance-related costs and
other.
2 Potential common shares are not included in the computation of diluted
earnings per share when a loss exists (or when dividends paid are greater than
income), as the effect would be an antidilutive per share amount. As a result,
the outstanding limited partnership units in the Company's operating partnership
("OP"), totaling 4,229,701 units were not included.
HEALTHCARE REALTY TRUST INCORPORATED HEALTHCAREREALTY.COM | PAGE 5 OF 7
FFO, Normalized FFO and FAD
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
TH… YE…
QU… TO FU…
EN… 20… 20… DA… 20… 20… YE… 2…
──────────────────────────────────────────────────────────────────────────────
N…
l…
a… $(… $(… $(… $(… $…
to
c…
s…
N…
l…
a…
to
c… $(… $(… $(… $(… $…
s…
p…
d…
s…
G…
on
s…
of -2… -7… -1… -9… -2…
r…
e…
a…
I…
of
r… 16… 10… 58… 25… 36…
e…
a…
R…
e…
d… 12… 14… 38… 45… 58…
a…
a…
N…
l…
f… -1… -8… -7… -3… -3…
o…
p…
u…
U…
JV
d…
a… 6,… 6,… 17… 20… 2…
g…
a…
i…
N… $1… $1… $3… $3… $…
F…
N…
F…
p…
c… $0… $0… $1… $1… $…
s…
-
d…
T… 1,… 125 4,… 1,… 2…
c…
D…
f… 25 3,… 1,… 3,… 5…
c…
R…
a… 2,… 12… 12… 22… 2…
s…
c…
M…
f… 9,… 10… 30… 31… 4…
v…
a…
O… 1,… 39 3,… 3,… 2…
N… $1… $1… $4… $4… $…
F…
N…
F…
p…
c… $0… $0… $1… $1… $…
s…
-
d…
N…
e…
d… 749 1,… 2,… 3,… 6…
a…
a…
N…
i… 1,… 1,… 4,… 3,… 5…
a…
n…
S…
a… -1… -6… -3… -2… -…
n…
S… 4,… 3,… 12… 10… 1…
c…
U…
JV -1… -4… -4… -1… -…
n…
i…
O… — 146 — 370 9…
M…
c… -3… -2… -8… -8… -…
a…
L…
F… $1… $1… $3… $3… $…
Q…
d…
a… $8… $8… $2… $3… $…
OP
d…
F…
w…
a…
c… 34… 35… 34… 35… 3…
s…
o…
-
d…
1 The Company utilizes the treasury stock method, which includes the dilutive
effect of nonvested share-based awards outstanding o f 722,102 for th e three
months ended September 30, 2026. Also includes the diluted impa ct of 4,229,701
OP units outstanding.
HEALTHCARE REALTY TRUST INCORPORATED HEALTHCAREREALTY.COM | PAGE 6 OF 7
Non-GAAP Measures
Management considers funds from operations ("FFO"), FFO per share, normalized
FFO, normalized FFO per share, and funds available for distribution ("FAD") to
be useful non-GAAP measures of the Company's operating performance. A non-GAAP
financial measure is generally defined as one that purports to measure
historical financial performance, financial position or cash flows, but excludes
or includes amounts that would not be so adjusted in the most comparable measure
determined in accordance with GAAP. Set forth below are descriptions of the non-
GAAP financial measures management considers relevant to the Company's business
and useful to investors.
The non-GAAP financial measures presented herein are not necessarily identical
to those presented by other real estate companies due to the fact that not all
real estate companies use the same definitions. These measures should not be
considered as alternatives to net income (determined in accordance with GAAP),
as indicators of the Company's financial performance, or as alternatives to cash
flow from operating activities (determined in accordance with GAAP) as measures
of the Company's liquidity, nor are these measures necessarily indicative of
sufficient cash flow to fund all of the Company's needs.
FFO and FFO per share are operating performance measures adopted by the National
Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines
FFO as “net income (computed in accordance with GAAP) excluding depreciation and
amortization related to real estate, gains and losses from the sale of certain
real estate assets, gains and losses from change in control, and impairment
write-downs of certain real assets and investments in entities when the
impairment is directly attributable to decreases in the value of depreciable
real estate held by the entity.” The Company defines Normalized FFO as FFO
excluding acquisition-related expenses and other normalizing items that are
unusual and infrequent in nature. FAD is presented by adding to Normalized FFO
non-real estate depreciation and amortization, deferred financing fees
amortization, and share-based compensation expense; and subtracting maintenance
capital expenditures, including second generation tenant improvements and
leasing commissions paid and straight-line rent income, net of expense. The
Company's definition of these terms may not be comparable to that of other real
estate companies as they may have different methodologies for computing these
amounts. FFO, Normalized FFO and FAD do not represent cash generated from
operating activities determined in accordance with GAAP and are not necessarily
indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD
should not be considered an alternative to net income as an indicator of the
Company’s operating performance or as an alternative to cash flow as a measure
of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with
GAAP financial measures.
Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per
share, and FAD provide an understanding of the operating performance of the
Company’s properties without giving effect to certain significant non-cash
items, including depreciation and amortization expense. Historical cost
accounting for real estate assets in accordance with GAAP assumes that the value
of real estate assets diminishes predictably over time. However, real estate
values instead have historically risen or fallen with market conditions. The
Company believes that by excluding the effect of depreciation, amortization,
gains or losses from sales of real estate, and other normalizing items that are
unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per
share and FAD can facilitate comparisons of operating performance between
periods. The Company reports these measures because they have been observed by
management to be the predominant measures used by the REIT industry and by
industry analysts to evaluate REITs and because these measures are consistently
reported, discussed, and compared by research analysts in their notes and
publications about REITs.
Cash NOI and Same Store Cash NOI are key performance indicators. Management
considers these to be supplemental measures that allow investors, analysts and
Company management to measure unlevered property-level operating results. The
Company defines Cash NOI as rental income plus interest from financing
receivables less property operating expenses. Cash NOI excludes non-cash items
such as above and below market lease intangibles, straight-line rent, lease
inducements, lease termination fees, financing receivable amortization, tenant
improvement amortization and leasing commission amortization. Cash NOI is
historical and not necessarily indicative of future results.
Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized
properties are properties that have been included in operations for the duration
of the year-over-year comparison period presented. Accordingly, stabilized
properties exclude properties that were recently acquired or disposed of,
properties classified as held for sale, properties undergoing redevelopment, and
newly redeveloped or developed properties.
The Company utilizes the redevelopment classification for properties where
management has approved a change in strategic direction through the application
of additional resources, including an amount of capital expenditures
significantly above routine maintenance and capital improvement expenditures.
Any recently acquired property will be included in the same store pool once the
Company has owned the property for five full quarters. Newly developed or
redeveloped properties will be included in the same store pool five full
quarters after substantial completion.
HEALTHCARE REALTY TRUST INCORPORATED HEALTHCAREREALTY.COM | PAGE 7 OF 7